The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
In vitro profiling of IDRX-42 against secondary and tertiary mutations (AP/AL) found in TKI-resistant GIST.
 
Michael Heinrich
Honoraria - Novartis
Consulting or Advisory Role - Cogent Pharmaceuticals; Deciphera; New Bay; Novartis; von Pfeffel Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent on treatment of GIST-licensed to Novartis (Inst)
Travel, Accommodations, Expenses - Deciphera
 
Ajia Town
No Relationships to Disclose
 
Marcelina Roberti
No Relationships to Disclose
 
Thomas Mühlenberg
No Relationships to Disclose
 
Sebastian Bauer
Honoraria - Deciphera; Pharmamar
Consulting or Advisory Role - Adcendo; Blueprint Medicines; Boehringer Ingelheim; Deciphera; IDRX
Research Funding - IDRX (Inst); von Pfeffel (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for a drug to treat a sarcoma subtype (Inst)